Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID-19 pandemic.
Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment.
Enhancement of breast CADx with unlabeled dataa).
Multidisciplinary care for women with early breast cancer in the Australian context.
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer. J Clin Oncol. 2018 03 20; 36(9):884-890.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Benzamides
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Middle Aged
Neoplasm Metastasis
Nitriles
Phenylthiohydantoin
Receptors, Androgen
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda